Brief: Germany's Merck Receives FDA Acceptance Of New Drug Application For Pimicotinib
Jan 13 (Reuters) - MERCK KGAA MRCG.DE: SAID ON MONDAY: FDA ACCEPTS NEW DRUG APPLICATION FOR PIMICOTINIB FOR THE TREATMENT OF TENOSYNOVIAL GIANT CELL TUMOR Further company coverage: MRCG.DE (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Merck KGaA
See all newsUS stocks weekly: AI reality
US stocks weekly: AI reality
Brief: Bio-Techne Co Will Be Required To Pay To Merck KGaA Termination Fee Equal To $230.5 Million If Deal Terminated Under Certain Circumstances - SEC Filing
Press Digest: Financial Times - June 26
US STOCKS-Wall St ends mixed as tech megacap declines outweigh upbeat chip outlook